Al18F-NOTA-FAP-2286

N/A

Report date: 2025/11/20 16:02:33

NME

Base Information

Drug NameAl18F-NOTA-FAP-2286

Drug Alias NameAl 18 F-NOTA-FAP-2286

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionFibroblast activation protein alpha binders

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesThe Affiliated Hospital Of Guizhou Medical University

China Registration ClassN/A

Develop Information

Active CompaniesThe Affiliated Hospital Of Guizhou Medical University

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A